Molecule
Brands
Company
Product Search
by Molecule
by Brands
by Company
NCE
Modified, Unique products
Recent KFDA Approval &
NHI enlisting
API Business info
Customer survey
Based on Production Vol.
DMF-Molecule, Status & Process
(Market & customer)
DMF Filling Status
Patent Status
My API profile Registration
Member's Lounge
General Market Information
KFDA registration process
DMF Filing
National Health Formulary enlisting
Law or Regulation
Major Pharmaceutical company
API importers directory
Distribution & Wholesaler
CRO & Other service Provider
Co-Biz Avenue
PharmaToday
Pharmaceutical Korea
Q & A
FAQ
General Q&A
Market Q&A
Business Inquiry
to Pharmalink
My Page
Company Registration
Company ID Management
Company Profile
Product description
>
API description
My Profile
Contacts in / out
General Q&A
Detail Information
Product Search
Detail Information
Antiphlamine Hydro24 Cataplasma
Company
Yuhan Corp.
ETC/OTC
OTC
MOHSA Class
ATC
M02AA
NHI Price
Reg/Mark
Not sale
Unit
5매/포
Pill ID
(Front) (Back)
Composition
loxoprofen sodium 56.7mg
Indication
Dosage
(카타플라스마제)(첩부제)
다음 질환 및 증상의 진통ㆍ 소염(항염): 퇴행성관절염(골(뼈)관절염), 근육통, 외상(상처)후의 종창(부기), 통증
(카타플라스마제)(첩부제)
1일 1회 1매 환부(질환 부위)에 부착한다.
Antiphlamine Hydro24 Cataplasma
[Close]
PharmaLink.kr
| Jin BD 2nd floor, Sadangdong 1039-59, Dongjak-Gu, Seoul
E-Mail :
pharmabase@nate.com
Tel : 82-70-7815-2200
Copyright ⓒ2013~2016 PharmaLink.Kr ALL RIGHTS RESERVED.